INE406A01037
INE406A01037
AUROBINDO PHARMA LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 974.11B EUR | 912.71B EUR | 757.6B EUR |
Enterprise Value | 930.22B EUR | 912.71B EUR | 766.41B EUR |
Valuation Multiples | |||
Trailing P/E | 26.45x | 24.74x | 21.28x |
Forward P/E | 18.14x | -- | -- |
Price to Sales | 2.79x | 2.66x | 2.26x |
Price to Book | 2.6x | -- | 2x |
EV/Revenue | 2.66x | 2.66x | 2.29x |
EV/EBITDA | 13.25x | 11.88x | 10.31x |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -- | -- | -- |